Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Integer Holdings Corp (ITGR)

Integer Holdings Corp (ITGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Integer Holdings Corp 5830 Granite Parkway Suite 1150 Plano TX 75024 USA

www.integer.net Employees: 11,000 P: 214-618-5243

Sector:

Medical

Description:

Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.

Key Statistics

Overview:

Market Capitalization, $K 4,185,643
Enterprise Value, $K 5,129,253
Shares Outstanding, K 34,892
Annual Sales, $ 1,717 M
Annual Net Income, $ 119,900 K
Last Quarter Sales, $ 437,390 K
Last Quarter Net Income, $ -22,490 K
EBIT, $ 218,510 K
EBITDA, $ 333,600 K
60-Month Beta 0.98
% of Insider Shareholders 2.16%
% of Institutional Shareholders 99.29%
Float, K 34,138
% Float 97.84%
Short Volume Ratio 0.80

Growth:

1-Year Return 2.31%
3-Year Return 77.01%
5-Year Return 65.94%
5-Year Revenue Growth 36.44%
5-Year Earnings Growth 13.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.31 on 04/24/25
Next Earnings Date 07/24/25 [BMO]
Earnings Per Share ttm 5.47
EPS Growth vs. Prev Qtr -8.39%
EPS Growth vs. Prev Year 14.91%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ITGR Ratios

Ratio
Price/Earnings ttm 22.26
Price/Earnings forward 19.24
Price/Earnings to Growth 1.05
Return-on-Equity % 11.95%
Return-on-Assets % 6.04%
Profit Margin % 6.98%
Debt/Equity 0.77
Price/Sales 2.48
Price/Cash Flow 13.67
Price/Book 2.64
Book Value/Share 46.05
Interest Coverage 3.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar